top of page

A novel intraocular implant that preserves the capsular form and intracapsular space. An unmet challenge in replacement of the natural lens by an IOL, preventing optimisation of the visual outcome! 

PCO, refractive surprise, Pseudophakic Dysphotopsia, IOL decentration and instability, anterior capsule phimosis, and PVD are the main associated complications.

Additional Complications

49% of patients will experience some aspect of dysphotopsia.²¹

0.21% to 1.40% incidence rate of capsular bag phimosis.²²

0.2% to 3% incidence rate of IOL dislocation.¹⁷⁻¹⁹

27.3% complete PVD with a 7-fold higher hazard risk ratio for progression to complete PVD.²³

A ground-breaking solution that defines a new era in cataract and refractive lens exchange surgery!

Shaped like a torus with a perfect balance of stability and flexibility, fixOflex™ is a medical implantable endocapsular device used during surgery prior to IOL implantation. It was designed to both fix the implanted IOL in its place and flex the empty capsule of the human crystalline lens to preserve its natural 3-D state and intracapsular volume. By doing so, it provides a platform that offers multitude of benefits.

2024
Initiation of official pediatric study
2012
Initial conception of the idea
2023
Completion of official clinical trials 
2017
 US Patent application
2019
Initiation of official clinical trials
2016
Initial peer reviewed publication
2020
US Patent application granted 
2018
Establishment of Eye PCR B and worldwide patent application
2023
Worldwide patent application granted in various countries
Expecting CE Mark by mid 2024
2016
Initial peer reviewed publication
2018
Establishment of EYE PCR BV and worldwide patent application
2020
USA patent application granted
2023
Completion of official clinical trials
2012
Initial conception of the idea
2017
US Patent application
2019
Initiation of official clinical trials 
2023
Worldwide patent application granted in various countries
2024
Initiation of official pediatric study
Expecting CE Mark by mid 2024

Eye PCR is pioneering a new chapter in eye care.

Dr. Ahmed Elmassry presented Abstract regarding Intraocular Lens Stabilisation with a novel implant

We report a case of a patient that was implanted with an intracapsular ring during phacoemulsification cataract surgery.

fixOflex was selected out of more than 45 emerging company applications to present a talk during the cataract extraction session.

Prof. Pallikaris along with EYE PCR team joined the 36th International Congress.

From January 27th to 29th 2022, the 27th Pallas Kliniken Ophthalmological Conference (OTO) took place with numerous highlights.

Eye PCR is participating with a presentation of fixOflex using the early outcome of a cohort of 108 patients from the on going Clinical Trial in Alexandria, Egypt.

EYE-PCR has presented a poster referring to the on going Clinical Trial in Alexandria. The early outcome of a cohort of 72 patients was promising. A video of Prof. Ioannis Pallikaris presenting the fixOflex Ring was released.

EYE PCR is happy to announce that the abstract submitted by Prof. Ahmed El Massry has been accepted for a poster presentation during the ESCRS 2020 annual congress.

Healio presents on Occular Surgery News video from the ESCRS 2022 in Milan

Prof. Pallikaris describes how to utilise the fixOflex during IOL implantation and discusses his 2022 ESCRS presentation.

Prof. Pallikaris’ presenting EYE PCR and fixOflex on iNovation day at ESCRS Milan

Eyewire prologuing EYE PCR’ s presentation on fixOflex at the ESCRS meeting in Milan

Embrace the future in IOL implantation with fixOflex by staying connected through our newsletter

bottom of page